Last Updated:
Searching
Create account to add to watchlist!

AEA-Bridges Impact Corp. - IMPX

  • Commons

    $9.83

    +0.00%

    IMPX Vol: 2.1K

  • Warrants

    $0.85

    -1.16%

    IMPX+ Vol: 39.3K

  • Units

    $10.21

    -0.29%

    IMPX= Vol: 0.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 393.2M
Average Volume: 43.3K
52W Range: $9.58 - $11.42
Weekly %: +0.00%
Monthly %: +0.00%
Inst Owners: 79

Info

Target: Searching
Days Since IPO: 422
Unit composition:
Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant
Trust Size: 40000000.0M

🕵Stocktwit Mentions

Watchthosestocks posted at 2021-11-26T15:45:22Z

I have been closely watching $IMPX and reading the filings. It's ESG focus, along with the recent filings make it a top pick for the current market sentiment. $BENE $BFRI and $GGPI have fared moderately well in this environment, but the ownership conviction and company selection criteria of $IMPX makes it a solid pick with potential to pass these (Although GGPI is very hot right now)-the right selection could send $IMPX higher given the somewhat smaller float Definitely worth the watch list going forward. I'm looking for a DA before the end of the year

Tickstocks posted at 2021-11-26T02:39:00Z

$IMPX Twits Stats Today's Change 6% + 🚀 https://t8sk.com/IMPX

T8skmod posted at 2021-11-22T02:33:03Z

$IMPX Twits St$CDNA Twits Stats Today's Change 6% + 🚀 https://t8sk.com/CDNAats Today's Change 6% + 🚀 https://t8sk.com/IMPX

T8skmod posted at 2021-11-22T02:32:08Z

$IMPX Twits Stats Today's Change 6% + 🚀 https://t8sk.com/IMPX

SSTx84 posted at 2021-11-19T13:14:21Z

$IMPX another possibility, Grove Collaborative, over $250M in revenue in 2020, raised $125M @ $1.3B in 12/2020. John Replogle formally of Seventh Generation which is a partner to Grove is on the $IMPX board. Recent Accounting Manager post looking for public company experience and 4/2021 article suggesting looking at going public.

stockballz posted at 2021-11-17T16:20:07Z

$IMPX 3Million in spending last quarter. Must have a target. ESG focused- could pull a European target. store dot, switch, octopus energy, British or North Volt. Or go US consumer focused- Grove Collaborative or the Big DAWG impossible Foods 🧐

Watchthosestocks posted at 2021-11-16T21:22:15Z

$IMPX This should be on the watchlist of traders for a DA before the EOY. Good signs pointing that way and their target is going to be a strong company that is profitable and excels in ESG. Great ownership profile already. This will run on the DA so keep it on watch $GGPI $DWAC $RBAC

stockballz posted at 2021-11-16T16:04:33Z

$IMPX green

T8skmod posted at 2021-11-16T05:01:07Z

$IMPX Twits Stats Today's Change 6% + 🚀 https://t8sk.com/IMPX

arpatel530 posted at 2021-11-15T18:43:09Z

$IMPX come on. Announce something. We are at peak esg

Doyz899 posted at 2021-11-15T18:42:59Z

$IMPX someone knows something. The volume had been crazy .

arpatel530 posted at 2021-11-15T16:47:30Z

$IMPX huge common volume. Are we going to get something

roje2021 posted at 2021-11-14T17:43:41Z

$IMPX Merger Monday coming up!

arpatel530 posted at 2021-11-11T19:59:17Z

$IMPX three days of very good warrant volume. Come on. Give us a DA

stockballz posted at 2021-11-11T17:01:07Z

$IMPX Another large volume in warrants …

Doyz899 posted at 2021-11-11T12:48:09Z

$IMPX

Hendrik04 posted at 2021-11-11T12:26:16Z

$IMPX had 3M USD in spending on legal costs and DD last quarter - Possible DA soon? Warrants just at $0.90 $IPOF $IPOD

Hendrik04 posted at 2021-11-11T12:24:02Z

$IMPX Warrants running on volume.. $IPOF $PSTH

SSTx84 posted at 2021-11-11T01:27:57Z

$IMPX again, why not? High hopes for this one regardless but with John Replogle, a consumer products guy, advising think this makes more sense than Britishvolt or Octopus Energy but who knows.

SSTx84 posted at 2021-11-11T01:22:55Z

$IMPX not all that “Impossible” $500M not too far from the $400M Trust. With the ticker already being IMPX would just be too obvious right?

arpatel530 posted at 2021-11-11T00:16:30Z

$IMPX let's get something. Massive volume. And after hours good

mars_voltron posted at 2021-11-11T00:05:25Z

$IMPX someone knows something or someone is going crazy with boredom and slapping asks lol who knows

stockballz posted at 2021-11-10T22:17:13Z

$IMPX Somebody knows something

FutureValue posted at 2021-11-10T20:54:12Z

$IMPX Something is brewing over here. Warrants seeing some very strong volume after 3pm today. Big seller at .85 was wiped out. DA Soon lets hope. ESG is hot.

arpatel530 posted at 2021-11-09T22:20:33Z

$BREZ $IMPX $ETAC can we get a fucking DA. Held these over a year

stockballz posted at 2021-11-09T16:47:45Z

$IMPX another huge warrant volume day 🧐

roje2021 posted at 2021-11-08T22:36:00Z

$IMPX I think this is ready for a DA drop. May only be a 2% pop but whatever atleast I can move on.

RicciR posted at 2021-11-08T18:45:45Z

$IMPX we will be moving north soon... load up!

roje2021 posted at 2021-11-08T13:32:59Z

$IMPX some interesting movement going on...

44milliondollarclub posted at 2021-11-07T15:53:14Z

$IMPX: My analysis based on price actions says, at the current price of $9.81, this stock is UNDERVALUED! Fair Price should be between $9.94-$11.93. My Sell Target from the fair price would be between $12.43-$13.92. 1 year ago from today, the stock was trading at $9.65 so at the current price, it's up 1.66%! 💲💸🚀📈🌑💰🗠🤑 Want me to analyze a stock in real-time, just tag me with any stock symbol & also follow me :) !

Management

Our officers and directors are as follows: Name Age Position John Garcia 64 Chair, Co-Chief Executive Officer and Director Michele Giddens 54 Co-Chief Executive Officer and Director Ramzi Gedeon 47 Chief Financial Officer, Secretary and Director Brian Trelstad 51 Director John Replogle 54 Independent Director Dr. Garcia is the Executive Chairman of AEA. He joined AEA in 1999 as a Partner and Head of AEA’s then newly-formed European operations based in London. In 2002, he became President of AEA while continuing to head European operations and lead AEA’s global Value-Added Industrial Products and Specialty Chemicals teams. In 2006, Dr. Garcia also became CEO of AEA, during which time he was responsible for all operational aspects of AEA including fundraising, investment review process, growth and strategy and operations. Dr. Garcia was also named Chairman of AEA in 2012 and in 2019, in connection with relinquishing the title of CEO, he became the Executive Chairman. As Executive Chairman, he remains responsible for AEA’s investment review process. Since 1999, under his leadership, AEA has made 75 private equity investments totaling over $9 billion of invested capital. He was also instrumental in the creation of the AEA Private Debt Funds in 2005 and the AEA Small Business Funds in 2004. Dr. Garcia has served on the board of numerous AEA portfolio companies in addition to various other companies. Dr. Garcia serves as the chairman or member of the investment committee for all the various AEA private equity and private debt funds. He has a long history of working together with family-owned and entrepreneur-led businesses and investors to help them maximize their potential and meet their long-term needs. Prior to joining AEA, Dr. Garcia held various positions at Credit Suisse First Boston including global head of the chemicals group and head of the European acquisitions, leveraged finance and financial sponsors group, and head of the European natural resources group. Earlier in his career, Dr. Garcia was a managing director at Schroder Wertheim in New York and held a number of industrial positions at Atlantic Richfield in Philadelphia, Pennsylvania. Dr. Garcia earned a B.Sc. from the University of Kent, an M.A. and Ph.D. in Organic Chemistry from Princeton University, and an M.B.A. from Wharton School of the University of Pennsylvania. Michele Giddens serves as our Co-CEO and on our board of directors. Ms. Giddens has almost 30 years of experience in international development and social finance. Ms. Giddens is a Co-CEO of Bridges Fund Management, which she founded alongside Philip Newborough and Sir Ronald Cohen in 2002. She has played a key role in the growth of the impact investing movement in the U.K. Ms. Giddens currently sits as a Non-Executive Director on the board of CDC, the UK Government’s Development Finance Institution. Ms. Giddens’s prior experience includes chairing the UK National Advisory Board on Impact Investing, part of the Global Social Impact Investment Steering Group, from 2016 to 2018, and sitting on the Council of the BVCA. She was previously an adviser to the U.K. Treasury’s Social Investment Task Force and chaired the Community Development Finance Association from 2003 to 2005. Ms. Giddens began her career with the International Finance Corporation, the private sector financing arm of the World Bank Group, where she ran small business lending programs in Russia, Central and Eastern Europe, and advised on microfinance in Bangladesh, the Middle East and Mongolia. She subsequently spent eight years with Shorebank Corporation, one of the leading community development banks in the United States. Ms. Giddens has a B.A. (with Honors) in Politics, Philosophy & Economics from Oxford University and an M.B.A. from Georgetown University, Washington, D.C., and was awarded an OBE for her services to international development and social finance in the 2018 Queen’s Birthday Honors list. Ramzi Gedeon serves as our Chief Financial Officer and on our board of directors. Mr. Gedeon is a Partner of AEA and has over 20 years of private equity investment experience. Mr. Gedeon focuses on AEA’s investments in Europe. Prior to joining AEA in 2018, Mr. Gedeon was a Partner at TPG Capital in London, 117 where he completed investments in various sectors including retail and consumer, industrials, building materials and technology and telecom. He has served on numerous boards and has closed transactions in several markets including the United Kingdom, Germany, France, Turkey, the Middle East and Australia. Mr. Gedeon began his career in investment banking at Merrill Lynch in New York, where he advised private equity firms on all aspects of their investment activities. Mr. Gedeon earned a B.A. (with Honors) in Economics from Cambridge University, and an M.A. in International and Development Economics from Yale University. Brian Trelstad serves on our board of directors. Mr. Trelstad has nearly 20 years of impact investing experience, and is currently a Partner at Bridges in the U.S. Sustainable Growth Fund, and a director of the Bridges Impact Foundation in the United States. His prior experience includes serving as the Chief Investment Officer of Acumen Fund, where he oversaw $55.0 million of investments into companies that were delivering health, water, energy and agriculture services in South Asia and Sub-Saharan Africa. Mr. Trelstad also served as a co-founding board member of the Aspen Network of Development Entrepreneurs and was one of the principal architects of the impact management software tool, Pulse, and the Impact Reporting and Investment Standards. Prior to Acumen Fund, Mr. Trelstad was a healthcare consultant at McKinsey & Company, was a lead environmental staff person at the Corporation for National Service, and has been involved in starting and advising a range of non-profit and for-profit start-ups. Brian has an undergraduate degree from Harvard University, an M.B.A. from Stanford’s Graduate School of Business, and an M.A. in City & Regional Planning from the University of California at Berkeley. He also teaches social entrepreneurship at Harvard Business School. Brian was the first impact investor to go through the Kauffman Fellows Program of the Center for Venture Education, and is a Henry Crown Fellow of the Aspen Institute. John Replogle is a leader in the conscious consumer and mission-driven brand movement, with extensive experience leading fast growth, high performing businesses including Seventh Generation and Burt’s Bees. Seventh Generation helped to launch the B Corp movement and has been awarded the “Best for the World” distinction from B Labs. Mr. Replogle believes that business is one of the most powerful forces on earth and such power must be harnessed for the greater good. He also served as President of Unilever’s Skin Care business and President of the Guinness Bass Import Company. Mr. Replogle started his career at the Boston Consulting Group and holds degrees from Harvard Business School and Dartmouth College. Recently, Mr. Replogle is a Founding Partner of One Better Ventures, a Real Leader 100 social impact firm that advises and invests in mission driven consumer goods companies. He serves on the Boards of Seventh Generation, Dartmouth, Leesa Sleep, Cree, Melissa & Doug, Beautycounter and BEST NC. He is an active environmentalist and champion of social entrepreneurs. Number and Terms of Office of Officers and Directors We will have five directors upon completion of this offering. Our board of directors is divided into three classes, with only one class of directors being appointed in each year, and with each class (except for those directors appointed prior to our first annual general meeting) serving a three-year term. In accordance with the NYSE corporate governance requirements, we are not required to hold an annual general meeting until one year after our first fiscal year end following our listing on the NYSE. The term of office of the first class of directors, consisting of John Replogle, will expire at our first annual general meeting. The term of office of the second class of directors, consisting of Ramzi Gedeon and Brian Trelstad, will expire at our second annual general meeting. The term of office of the third class of directors, consisting of John Garcia and Michele Giddens, will expire at our third annual general meeting. Prior to the completion of an initial business combination, any vacancy on the board of directors may be filled by a nominee chosen by holders of a majority of our founder shares. In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason. Pursuant to an agreement to be entered into on or prior to the closing of this offering, our sponsor, upon and following consummation of an initial business combination, will be entitled to nominate three individuals for 118 appointment to our board of directors, as long as the sponsor holds any securities covered by the registration and shareholder rights agreement. Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate. Our amended and restated memorandum and articles of association will provide that our officers may consist of one or more chairman of the board, chief executive officer, president, chief financial officer, vice presidents, secretary, treasurer and such other offices as may be determined by the board of directors. Director Independence NYSE listing standards require that a majority of our board of directors be independent. Our board of directors has determined that John Replogle is an “independent director” as defined in the NYSE listing standards. Our independent directors will have regularly scheduled meetings at which only independent directors are present. Executive Officer and Director Compensation None of our executive officers or directors have received any cash compensation for services rendered to us. Commencing on the date that our securities are first listed on the NYSE through the earlier of consummation of our initial business combination and our liquidation, we will reimburse an affiliate of our sponsor for office space, secretarial and administrative services provided to us in the amount of $10,000 per month. In addition, our sponsor, executive officers and directors, or their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our sponsor, executive officers or directors, or their affiliates. Any such payments prior to an initial business combination will be made using funds held outside the trust account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional controls in place governing our reimbursement payments to our directors and executive officers for their out-of-pocket expenses incurred in connection with our activities on our behalf in connection with identifying and consummating an initial business combination. Other than these payments and reimbursements, no compensation of any kind, including finder’s and consulting fees, will be paid by the company to our sponsor, executive officers and directors, or their respective affiliates, prior to completion of our initial business combination. After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting or management fees from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the proxy solicitation materials or tender offer materials furnished to our shareholders in connection with a proposed business combination. We have not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation will be known at the time of the proposed business combination, because the directors of the post-combination business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our executive officers will be determined, or recommended to the board of directors for determination, either by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our board of directors. We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our executive officers and directors may negotiate employment or consulting arrangements to remain with 119 us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our executive officers and directors that provide for benefits upon termination of employment. Committees of the Board of Directors Upon the effectiveness of the registration statement of which this prospectus forms a part, our board of directors will have three standing committees: an audit committee, a nominating committee and a compensation committee. Subject to phase-in rules and a limited exception, the rules of the NYSE and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors. Subject to phase-in rules and a limited exception, the rules of the NYSE require that the compensation committee and the nominating committee of a listed company be comprised solely of independent directors. Audit Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish an audit committee of the board of directors. John Replogle will serve as a member of our audit committee. Our board of directors has determined that John Replogle is independent under the NYSE listing standards and applicable SEC rules. John Replogle will serve as the Chairman of the audit committee. Under the NYSE listing standards and applicable SEC rules, all the directors on the audit committee must be independent. Each member of the audit committee is financially literate and our board of directors has determined that John Replogle qualifies as an “audit committee financial expert” as defined in applicable SEC rules. The audit committee is responsible for: • meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems; • monitoring the independence of the independent registered public accounting firm; • verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; • inquiring and discussing with management our compliance with applicable laws and regulations; • pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; • appointing or replacing the independent registered public accounting firm; • determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; • establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; • monitoring compliance on a quarterly basis with the terms of this offering and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of this offering; and 120 • reviewing and approving all payments made to our existing shareholders, executive officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our board of directors, with the interested director or directors abstaining from such review and approval. Nominating Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish a nominating committee of our board of directors. John Replogle will serve as a member and chairman of the nominating committee. Under the NYSE listing standards, we are required to have a nominating committee composed entirely of independent directors. Our board of directors has determined that John Replogle is independent. The nominating committee is responsible for overseeing the selection of persons to be nominated to serve on our board of directors. The nominating committee considers persons identified by its members, management, shareholders, investment bankers and others. Guidelines for Selecting Director Nominees The guidelines for selecting nominees, which will be specified in a charter to be adopted by us, generally will provide that persons to be nominated: • should have demonstrated notable or significant achievements in business, education or public service; • should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and • should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders. The nominating committee will consider a number of qualifications relating to management and leadership experience, background and integrity and professionalism in evaluating a person’s candidacy for membership on the board of directors. The nominating committee may require certain skills or attributes, such as financial or accounting experience, to meet specific board needs that arise from time to time and will also consider the overall experience and makeup of its members to obtain a broad and diverse mix of board members. The nominating committee does not distinguish among nominees recommended by shareholders and other persons. Compensation Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish a compensation committee of our board of directors. John Replogle will serve as a member and chairman of the compensation committee. Under the NYSE listing standards, we are required to have a compensation committee composed entirely of independent directors. Our board of directors has determine

Holder Stats

1 0
% of Shares Held by All Insider 6.25%
% of Shares Held by Institutions 75.35%
% of Float Held by Institutions 80.38%
Number of Institutions Holding Shares 79

Mutual Fund Holders

Holder Shares Date Reported Value % Out
Collaborative Inv Ser Tr-SPAC and New Issue ETF 183390 2021-06-29 1786218 0.45999999999999996
Saba Capital Income & Opportunities Fd 131209 2021-08-30 1280599 0.33
BlackRock Global Impact Fund 32752 2021-07-30 319004 0.08
Franklin K2 Alternative Strategies Fd 28592 2021-08-30 279057 0.07
Gabelli Love Our Planet & People ETF 9310 2021-06-29 90679 0.02
BlackRock U.S. Impact Fund 7294 2021-07-30 71043 0.02
Greenspring Fund, Incorporated 4000 2021-09-29 39120 0.01

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-16 Beryl Capital Management LLC 482,727 $4,720,000 0.3% +30.2% 0.965%
2021-11-15 Berkley W R Corp 454,862 $4,450,000 0.3% +110.1% 0.910%
2021-11-15 Hunting Hill Global Capital LLC 17,661 $170,000 0.1% 0 0.035%
2021-11-15 Dark Forest Capital Management LP 86,662 $850,000 0.3% 0 0.173%
2021-11-15 HighTower Advisors LLC 747,717 $7,320,000 0.0% -2.5% 1.495%
2021-11-12 Gabelli Funds LLC 10,460 $100,000 0.0% 0 0.021%
2021-11-12 Periscope Capital Inc. 1,351,050 $13,210,000 0.4% +1.3% 2.702%
2021-11-12 Weiss Asset Management LP 112,000 $1,100,000 0.0% +124.0% 0.224%
2021-11-10 MMCAP International Inc. SPC 318,090 $3,110,000 0.2% -20.0% 0.636%
2021-10-22 Tuttle Capital Management LLC 143,573 $1,400,000 0.7% -21.7% 0.287%
2021-08-17 Kohlberg Kravis Roberts & Co. L.P. 114,420 $1,110,000 0.0% 0 0.229%
2021-08-17 Northern Right Capital Management L.P. 93,778 $910,000 0.3% -81.8% 0.188%
2021-08-17 Citadel Advisors LLC 43,807 $430,000 0.0% +8.4% 0.088%
2021-08-17 Beryl Capital Management LLC 370,899 $3,610,000 0.3% -46.2% 0.742%
2021-08-16 Schonfeld Strategic Advisors LLC 73,164 $710,000 0.0% +171.7% 0.146%
2021-08-16 Bloom Tree Partners LLC 286,818 $2,790,000 0.3% +0.7% 0.574%
2021-08-13 Alpine Global Management LLC 190,649 $1,860,000 0.3% +20.7% 0.381%
2021-08-12 Penserra Capital Management LLC 12,634 $120,000 0.0% 0 0.025%
2021-08-12 Commonwealth of Pennsylvania Public School Empls Retrmt SYS 50,000 $490,000 0.0% +28.8% 0.100%
2021-08-12 CIBC World Markets Inc. 51,500 $500,000 0.0% 0 0.103%
2021-08-11 Arena Capital Advisors LLC CA 4,130 $40,000 0.0% 0 0.008%
2021-08-11 Susquehanna International Group LLP 16,359 $160,000 0.0% -12.9% 0.033%
2021-08-06 HighTower Advisors LLC 766,964 $7,470,000 0.0% +17.5% 1.534%
2021-08-03 Landscape Capital Management L.L.C. 19,348 $190,000 0.0% 0 0.039%
2021-07-31 Tuttle Tactical Management 183,390 $1,790,000 0.8% -32.9% 0.367%
2021-05-18 D. E. Shaw & Co. Inc. 255,533 $2,510,000 0.0% 0 0.511%
2021-05-18 Verition Fund Management LLC 50,000 $490,000 0.0% 0 0.100%
2021-05-18 Berkley W R Corp 216,494 $2,130,000 0.2% -27.4% 0.433%
2021-05-18 Morgan Stanley 21,485 $210,000 0.0% 0 0.043%
2021-05-18 Citadel Advisors LLC 40,413 $400,000 0.0% 0 0.081%
2021-05-18 TIG Advisors LLC 13,384 $130,000 0.0% 0 0.027%
2021-05-17 Schonfeld Strategic Advisors LLC 26,929 $260,000 0.0% -61.7% 0.054%
2021-05-17 Brant Point Investment Management LLC 390,342 $3,830,000 0.4% +8.4% 0.781%
2021-05-17 Vivaldi Capital Management LLC 11,058 $110,000 0.0% +10.6% 0.022%
2021-05-17 CSS LLC IL 203,227 $2,000,000 0.1% -33.8% 0.406%
2021-05-17 HBK Investments L P 450,000 $4,420,000 0.0% -28.0% 0.900%
2021-05-17 Nomura Holdings Inc. 50,000 $490,000 0.0% 0 0.100%
2021-05-17 Governors Lane LP 745,000 $7,320,000 0.5% 0 1.490%
2021-05-17 Marathon Trading Investment Management LLC 41,400 $410,000 0.0% 0 0.083%
2021-05-17 Centiva Capital LP 30,000 $300,000 0.0% -63.0% 0.060%
2021-05-14 Arrowstreet Capital Limited Partnership 61,701 $610,000 0.0% 0 0.123%
2021-05-14 Weiss Asset Management LP 50,000 $490,000 0.0% -81.5% 0.100%
2021-05-14 Dynamic Technology Lab Private Ltd 10,017 $98,000 0.0% -49.9% 0.020%
2021-05-13 Wolverine Asset Management LLC 35,746 $350,000 0.0% -79.4% 0.071%
2021-05-13 Alpine Global Management LLC 157,999 $1,550,000 0.1% 0 0.316%
2021-05-12 Commonwealth of Pennsylvania Public School Empls Retrmt SYS 38,805 $380,000 0.0% +181.1% 0.078%
2021-05-12 CIBC Private Wealth Group LLC 195,646 $1,920,000 0.0% +6.2% 0.391%
2021-05-10 HighTower Advisors LLC 652,838 $6,410,000 0.0% +691.3% 1.306%
2021-05-04 LGL Partners LLC 14,862 $150,000 0.1% 0 0.030%
2021-05-04 Picton Mahoney Asset Management 350,000 $2,540,000 0.1% +40.0% 0.700%
2021-04-27 Tuttle Tactical Management 273,307 $2,680,000 1.1% +565.3% 0.547%
2021-04-26 Clean Yield Group 18,825 $190,000 0.1% 0 0.038%
2021-02-16 Vivaldi Capital Management LLC 10,000 $100,000 0.0% 0 0.019%
2021-02-12 Brant Point Investment Management LLC 360,000 $3,640,000 0.4% 0 0.699%
2021-02-11 Dynamic Technology Lab Private Ltd 20,000 $200,000 0.0% 0 0.039%
2021-02-11 Athos Capital Ltd 200,600 $2,029,999 0.6% 0 0.390%
2021-02-10 HighTower Advisors LLC 82,500 $840,000 0.0% 0 0.160%
2021-02-08 Alliancebernstein L.P. 164,144 $1,660,000 0.0% 0 0.319%
2021-01-20 Tuttle Tactical Management 41,078 $420,000 0.3% 0 0.080%

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q 10-Q 2021-11-05 https://www.sec.gov/Archives/edgar/data/1820191/000119312521321744/d248615d10q.htm
3 FORM 3 SUBMISSION 2021-10-01 https://www.sec.gov/Archives/edgar/data/1820191/000089924321038630/xslF345X02/doc3.xml
8-K 8-K 2021-10-01 https://www.sec.gov/Archives/edgar/data/1820191/000119312521289514/d233577d8k.htm
10-Q FORM 10-Q 2021-08-06 https://www.sec.gov/Archives/edgar/data/1820191/000119312521238956/d199392d10q.htm
10-Q FORM 10-Q 2021-06-25 https://www.sec.gov/Archives/edgar/data/1820191/000119312521199148/d171865d10q.htm
10-K/A FORM 10-K/A 2021-06-24 https://www.sec.gov/Archives/edgar/data/1820191/000119312521198599/d184945d10ka.htm
8-K 8-K 2021-06-24 https://www.sec.gov/Archives/edgar/data/1820191/000119312521198505/d175190d8k.htm
8-K 8-K 2021-05-28 https://www.sec.gov/Archives/edgar/data/1820191/000119312521177172/d100830d8k.htm
NT 10-Q NT 10-Q 2021-05-18 https://www.sec.gov/Archives/edgar/data/1820191/000119312521164920/d170394dnt10q.htm
10-K FORM 10-K 2021-03-31 https://www.sec.gov/Archives/edgar/data/1820191/000119312521100910/d145542d10k.htm
4 FORM 4 SUBMISSION 2021-02-19 https://www.sec.gov/Archives/edgar/data/1820191/000089924321007424/xslF345X03/doc4.xml
SC 13D SC 13D 2021-02-19 https://www.sec.gov/Archives/edgar/data/1820191/000119312521049138/d109962dsc13d.htm
SC 13G SC 13G 2021-02-16 https://www.sec.gov/Archives/edgar/data/1820191/000119312521044747/d134379dsc13g.htm
SC 13G 2021-02-16 https://www.sec.gov/Archives/edgar/data/1820191/000107680921000091/impx20201231.htm
SC 13G AEA-BRIDGES IMPACT CORP. 2021-02-08 https://www.sec.gov/Archives/edgar/data/1820191/000090266421000961/p21-0485sc13g.htm
SC 13G/A 2021-01-22 https://www.sec.gov/Archives/edgar/data/1820191/000131924421000035/IMPX_SC13GA1.htm
4 FORM 4 SUBMISSION 2020-11-23 https://www.sec.gov/Archives/edgar/data/1820191/000089924320031883/xslF345X03/doc4.xml
8-K 8-K 2020-11-20 https://www.sec.gov/Archives/edgar/data/1820191/000119312520299260/d36296d8k.htm
10-Q 10-Q 2020-11-13 https://www.sec.gov/Archives/edgar/data/1820191/000119312520293230/d65399d10q.htm
SC 13G 2020-10-15 https://www.sec.gov/Archives/edgar/data/1820191/000090266420003637/p20-1845sc13g.htm
SC 13G 2020-10-09 https://www.sec.gov/Archives/edgar/data/1820191/000131924420000143/IMPX_SC13G.htm
8-K 8-K 2020-10-09 https://www.sec.gov/Archives/edgar/data/1820191/000119312520267048/d62149d8k.htm
8-K 8-K 2020-10-07 https://www.sec.gov/Archives/edgar/data/1820191/000119312520265560/d939476d8k.htm
424B4 424B4 2020-10-02 https://www.sec.gov/Archives/edgar/data/1820191/000119312520262635/d95576d424b4.htm
EFFECT 2020-10-01 https://www.sec.gov/Archives/edgar/data/1820191/999999999520002656/xslEFFECTX01/primary_doc.xml
3 FORM 3 SUBMISSION 2020-10-01 https://www.sec.gov/Archives/edgar/data/1820191/000089924320026649/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-01 https://www.sec.gov/Archives/edgar/data/1820191/000089924320026648/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-01 https://www.sec.gov/Archives/edgar/data/1820191/000089924320026647/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-01 https://www.sec.gov/Archives/edgar/data/1820191/000089924320026645/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-01 https://www.sec.gov/Archives/edgar/data/1820191/000089924320026644/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-01 https://www.sec.gov/Archives/edgar/data/1820191/000089924320026640/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-10-01 https://www.sec.gov/Archives/edgar/data/1820191/000089924320026639/xslF345X02/doc3.xml
CERT NYSE CERTIFICATION 2020-10-01 https://www.sec.gov/Archives/edgar/data/1820191/000087666120000855/IMPX093020.pdf
8-A12B 8-A12B 2020-09-30 https://www.sec.gov/Archives/edgar/data/1820191/000119312520259952/d36898d8a12b.htm
CORRESP 2020-09-30 https://www.sec.gov/Archives/edgar/data/1820191/000119312520259244/filename1.htm
CORRESP 2020-09-30 https://www.sec.gov/Archives/edgar/data/1820191/000119312520259242/filename1.htm
UPLOAD 2020-09-29 https://www.sec.gov/Archives/edgar/data/1820191/000000000020009125/filename1.pdf
CORRESP 2020-09-29 https://www.sec.gov/Archives/edgar/data/1820191/000119312520257352/filename1.htm
S-1/A S-1/A 2020-09-29 https://www.sec.gov/Archives/edgar/data/1820191/000119312520257350/d88883ds1a.htm
S-1/A S-1/A 2020-09-23 https://www.sec.gov/Archives/edgar/data/1820191/000119312520252433/d88883ds1a.htm
CORRESP 2020-09-14 https://www.sec.gov/Archives/edgar/data/1820191/000119312520245268/filename1.htm
S-1 FORM S-1 2020-09-14 https://www.sec.gov/Archives/edgar/data/1820191/000119312520245263/d88883ds1.htm
UPLOAD 2020-09-04 https://www.sec.gov/Archives/edgar/data/1820191/000000000020008364/filename1.pdf
DRS 2020-08-07 https://www.sec.gov/Archives/edgar/data/1820191/000095012320007956/filename1.htm